Clinical Trial Update: Fecal Microbiota Therapy Vs 5-aminosalicylates for Induction of Remission in Newly Diagnosed Mild-moderately Active UC [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial compares fecal microbiota therapy with 5-aminosalicylates for induction of remission in newly diagnosed mild-to-moderately active ul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• 5-aminosalicylates (mesalamine) (mesalamine)
• Fecal microbiota therapy (fecal microbiota transplantation)

Snippet

Sponsor: Dayanand Medical College and Hospital | Conditions: Ulcerative Colitis Chronic Mild, Ulcerative Colitis Chronic Moderate | Phase 3 | Status: UNKNOWN